Advertisement

Molecular Biology Reports

, Volume 46, Issue 3, pp 2771–2778 | Cite as

Long non-coding RNA SNHG6 is upregulated in prostate cancer and predicts poor prognosis

  • Youji Yan
  • Zhongjun Chen
  • Yu Xiao
  • Xinghuan Wang
  • Kaiyu QianEmail author
Original Article
  • 143 Downloads

Abstract

Certain long non-coding RNAs (lncRNAs) have been reported to be differentially expressed in various human cancer types, including prostate cancer (PCa). PCa is the most commonly diagnosed cancer type in men and lacks sensitive and accurate biomarkers. Emerging studies have indicated that certain lncRNAs are dysregulated and have crucial roles in PCa progression. The present study reported that the novel lncRNA small nucleolar RNA host gene 6 (SNHG6) is overexpressed in PCa compared with that in normal prostate tissues. In The Cancer Genome Atlas and Taylor datasets, high expression of SNHG6 in PCa tissues was identified to be significantly associated with shorter disease-free survival. In order to reveal the potential mechanisms of the role of SNHG6 in PCa, SNHG6-associated protein–protein interaction networks were constructed. Bioinformatics analysis revealed that these SNHG6-interacting genes were associated with translation, nuclear-transcribed mRNA catabolic process, ribosomal RNA processing and mRNA splicing. Although further functional validation is warranted, the present study suggests that SNHG6 is a potential novel therapeutic target and prognostic biomarker for PCa.

Keywords

Prostate cancer Long non-coding RNA Small nucleolar RNA host gene 6 Protein–protein interaction network Biomarker 

Notes

Funding

This study was supported in part by Grants from the Hubei Province Health and Family Planning Scientific Research Project (Grant No. WJ2017H0002 to YX) and the Natural Science Foundation of Hubei Province (Grant No. 2014CFA006 to XW). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors disclose no potential conflicts of interest.

References

  1. 1.
    Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10(3):155–159CrossRefGoogle Scholar
  2. 2.
    Liu P, Tang H, Wu J, Qiu X, Kong Y, Zhang L, Xie X, Xiao X (2018) Linc01638 promotes tumorigenesis in HER2 + breast cancer. Curr Cancer Drug Targets 19(1):74CrossRefGoogle Scholar
  3. 3.
    Kong F, Deng X, Kong X, Du Y, Li L, Zhu H, Wang Y, Xie D, Guha S, Li Z, Guan M, Xie K (2018) ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF. Oncogene 37(45):5982CrossRefGoogle Scholar
  4. 4.
    Chang Z, Cui J, Song Y (2018) Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer. Gene 654:36–42CrossRefGoogle Scholar
  5. 5.
    Chen X, Yang C, Xie S, Cheung E (2018) Long non-coding RNA GAS5 and ZFAS1 are prognostic markers involved in translation targeted by miR-940 in prostate cancer. Oncotarget 9(1):1048–1062Google Scholar
  6. 6.
    Yan K, Tian J, Shi W, Xia H, Zhu Y (2017) LncRNA SNHG6 is Associated with poor prognosis of gastric cancer and promotes cell proliferation and EMT through epigenetically silencing p27 and sponging miR-101-3p. Cell Physiol Biochem 42(3):999–1012CrossRefGoogle Scholar
  7. 7.
    Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera JM, Bubley GJ, Li V, Rubin MA, Libermann TA, Sanda MG (2009) Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin Cancer Res 15(18):5794–5802CrossRefGoogle Scholar
  8. 8.
    Satake H, Tamura K, Furihata M, Anchi T, Sakoda H, Kawada C, Iiyama T, Ashida S, Shuin T (2010) The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer. Oncol Rep 23(1):11–16Google Scholar
  9. 9.
    Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45(D1):D362–D368CrossRefGoogle Scholar
  10. 10.
    Franceschini A, Lin J, von Mering C, Jensen LJ (2016) SVD-phy: improved prediction of protein functional associations through singular value decomposition of phylogenetic profiles. Bioinformatics 32(7):1085–1087CrossRefGoogle Scholar
  11. 11.
    Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von Mering C (2015) STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43(Database issue):D447–D452CrossRefGoogle Scholar
  12. 12.
    Pickard MR, Mourtada-Maarabouni M, Williams GT (2013) Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta 1832(10):1613–1623CrossRefGoogle Scholar
  13. 13.
    Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, Lawrence TS, Chinnaiyan AM, Feng FY (2014) The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia 16(11):900–908CrossRefGoogle Scholar
  14. 14.
    Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, Isogai T, Morant R, Castori-Eppenberger S, Chi KN, Wang Y, Helgason CD (2014) Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget 5(3):764–774CrossRefGoogle Scholar
  15. 15.
    Srikantan V, Zou Z, Petrovics G, Xu L, Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino K, Buzard GS, Mostofi FK, McLeod DG, Moul JW, Srivastava S (2000) PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci USA 97(22):12216–12221CrossRefGoogle Scholar
  16. 16.
    Petrovics G, Zhang W, Makarem M, Street JP, Connelly R, Sun L, Sesterhenn IA, Srikantan V, Moul JW, Srivastava S (2004) Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23(2):605–611CrossRefGoogle Scholar
  17. 17.
    Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, Merkurjev D, Ohgi KA, Meng D, Zhang J, Evans CP, Rosenfeld MG (2013) lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 500(7464):598–602CrossRefGoogle Scholar
  18. 18.
    Engreitz JM, Pandya-Jones A, McDonel P, Shishkin A, Sirokman K, Surka C, Kadri S, Xing J, Goren A, Lander ES, Plath K, Guttman M (2013) The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science 341(6147):1237973CrossRefGoogle Scholar
  19. 19.
    Du Y, Weng XD, Wang L, Liu XH, Zhu HC, Guo J, Ning JZ, Xiao CC (2017) LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression. Oncotarget 8(55):94358–94370CrossRefGoogle Scholar
  20. 20.
    Groskopf J, Aubin SM, Deras IL, Blase A, Bodrug S, Clark C, Brentano S, Mathis J, Pham J, Meyer T, Cass M, Hodge P, Macairan ML, Marks LS, Rittenhouse H (2006) APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem 52(6):1089–1095CrossRefGoogle Scholar
  21. 21.
    Hessels D, van Gils MP, van Hooij O, Jannink SA, Witjes JA, Verhaegh GW (2010) Schalken J. A. Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer. Prostate 70(1):10–16CrossRefGoogle Scholar
  22. 22.
    Chang L, Yuan Y, Li C, Guo T, Qi H, Xiao Y, Dong X, Liu Z, Liu Q (2016) Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Lett 383(2):183–194CrossRefGoogle Scholar
  23. 23.
    Cao C, Zhang T, Zhang D, Xie L, Zou X, Lei L, Wu D, Liu L (2017) The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene 36(8):1112–1122CrossRefGoogle Scholar
  24. 24.
    Meng Q, Yang BY, Liu B, Yang JX, Sun Y (2018) Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p. Int J Biol Markers 33(2):148–155CrossRefGoogle Scholar
  25. 25.
    Guo T, Wang H, Liu P, Xiao Y, Wu P, Wang Y, Chen B, Zhao Q, Liu Z, Liu Q (2018) SNHG6 Acts as a Genome-Wide Hypomethylation Trigger via Coupling of miR-1297-Mediated S-adenosylmethionine-dependent positive feedback loops. Cancer Res 78(14):3849–3864CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of UrologyZhongnan Hospital of Wuhan UniversityWuhanChina
  2. 2.Department of Urology, Jingzhou Central Hospital, The Second Clinical CollegeYangtze UniversityJingzhouChina
  3. 3.Department of Biological RepositoriesZhongnan Hospital of Wuhan UniversityWuhanChina
  4. 4.Human Genetics Resource Preservation Center of Hubei ProvinceWuhanChina
  5. 5.Laboratory of Precision MedicineZhongnan Hospital of Wuhan UniversityWuhanChina

Personalised recommendations